E

Elucidata

222 employees

Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.

Basic info

Industry

software development

Sectors

Biotechnology
Clinical Omics Data
Analytical Pipelines
Artificial Intelligence
SaaS
Single Cell Data
Bulk RNA-Seq Data
Drug Targets
Drug Discovery
Clinical Trials
Machine Learning
Analytics
Data Integration
Life Sciences
Health Care
Automated Curation
Biomedical Data
Software
FAIR Data
Bioinformatics
Life Science

Date founded

2015

Funding rounds raised

Total raised

$16M

from 6 investors over 6 rounds

E

Elucidata raised $16M on September 27, 2022

Investors: Hyperplane Venture Capital, IvyCap Ventures Advisors Private Limited and F-Prime Capital Partners

E

Elucidata raised $5M on January 28, 2021

Investors: IvyCap Ventures Advisors Private Limited and Hyperplane Venture Capital

E

Elucidata raised $1.7M on June 18, 2018

Investors: Hyperplane Venture Capital

FAQ